MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis - Wikidata - thesis-toulmin - TriplyDB

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

http://www.wikidata.org/entity/Q24643421

about

Prevalence of kidney disease in HIV-infected and uninfected Rwandan women Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans Reconciling apparent conflicts between mitochondrial and nuclear phylogenies in African elephants African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans Association of trypanolytic ApoL1 variants with kidney disease in African Americans Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans New loci associated with kidney function and chronic kidney disease APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy APOL1 localization in normal kidney and nondiabetic kidney disease Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene MYH9 is associated with nondiabetic end-stage renal disease in African Americans FSGS: Diagnosis and Diagnostic Work-Up Ethnic Differences in Childhood Nephrotic Syndrome Genes Caught In Flagranti: Integrating Renal Transcriptional Profiles With Genotypes and Phenotypes Insights into the genetic architecture of diabetic nephropathy Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction Genome-wide association studies of chronic kidney disease: what have we learned?Hypertension and chronic kidney disease: controversies in pathogenesis and treatment Cell biology and pathology of podocytes Genes and podocytes - new insights into mechanisms of podocytopathy Developments in renal pharmacogenomics and applications in chronic kidney disease Mendelian and trans-generational inheritance in hypertensive renal disease HIV and chronic kidney disease Addressing the global burden of chronic kidney disease through clinical and translational research APOL1 and nephropathy progression in populations of African ancestry APOL1 kidney risk alleles: population genetics and disease associations Genetic and epigenetic factors influencing chronic kidney disease The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease Update on current management of chronic kidney disease in patients with HIV infection Pathophysiology of Non Alcoholic Fatty Liver Disease The African diaspora: history, adaptation and health Genetics and Epigenetics of Diabetic Nephropathy Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome Trans-ethnic genome-wide association studies: advantages and challenges of mapping in diverse populations.Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa Genetic variation and adaptation in Africa: implications for human evolution and disease A genome-wide association search for type 2 diabetes genes in African Americans

P2860

Q21034190-7B2FEE4E-766D-47D6-B394-E4EE2C75D74F Q21144945-DDCB47E5-B5FE-48D4-B5AE-C98235718CCF Q21560812-5B533D15-9BDA-4978-A5E1-A64A977B2BC0 Q24602407-84D09C93-B17B-447E-8DC5-34F134420A16 Q24606581-B1A08015-ECB4-4E14-91D2-E5260AF17030 Q24621889-E2CF65B7-44E4-4624-B539-D034D9FB2B0F Q24630646-C8E967D5-4605-4C87-9A57-7BB173791B22 Q24631837-504E77EA-DA3D-48E2-B079-A4ABE791748D Q24631960-101B6741-87FD-4B6A-B7FB-74F1EDFA1DDF Q24632288-720220BE-FFEB-469C-8B79-C76009EC5966 Q24653027-254E8566-411A-4E57-8E9C-5470EE477DBB Q26744558-5180A848-AD06-455E-942A-7E2F03AAF0A7 Q26752347-A948A168-C8A7-4394-B43E-6F0E446A142A Q26799187-64AE9A6A-F2A0-4351-9688-AF42AE6619F1 Q26823352-6F512A40-0431-41D7-8D57-590EB9CE78ED Q26824460-2CAB2D28-815A-4DA7-9D39-6D61BCABB949 Q26825851-7A55C276-8362-41DA-912D-47A405D87A1F Q26851271-0452BE7D-6B5F-4821-9D3F-87F8782DC275 Q26853664-6A6523DD-1E13-4307-9A50-BC0CA3C59D55 Q26866422-56321A5E-23EA-47A4-A2E9-7A931D25C8CC Q26999279-079885A3-2B12-4BAE-9845-132623E9ACDF Q27009363-BBC3A49A-DF5D-439E-831E-FFD4BE4C8E96 Q27010688-CCFE4374-1B6B-4A88-BFD5-549CE6C28F4B Q27014158-8008F171-650E-4C5A-B6B0-0069D56898BF Q27022275-50F5E5CC-113F-4EBD-BAD0-FFD444E3FB5A Q27024261-C7B4C169-DAED-4E9A-916D-7AB1A3253603 Q27024548-19B27917-AAA1-4A6D-8F57-3D6C220C3D9D Q27027828-98B1D3D5-452A-4A21-838B-9320F4185740 Q27691460-415FC88C-7F64-4C97-A170-CCCCDE9B9101 Q28070011-2C60B5B0-2677-49E9-B1E7-D0C72A37795F Q28075805-949ABDDB-3856-4F4B-A08B-F045C8B30D4E Q28084549-C16219F6-D01F-4A38-B48F-4CD99B73F355 Q28256662-C149E67D-66DA-4CCA-B636-8BC7F1218922 Q28383497-70C66C05-DEC0-421B-BA10-FCA2E79E8F69 Q28391758-7CEE53F8-315D-43A3-A5DA-AEF572F11036 Q28535213-CFF713DE-B1FD-49D4-8822-EB6D98497893 Q28546164-23E4A2C2-6F14-4F19-A39A-FABE8C65F37A Q28606687-6F50EA36-C732-477E-BA09-A46F43994D3B Q28657760-D365260E-D224-450A-B69A-8889045E5A5E Q28740367-BE3900FC-52F8-40E9-AF04-043A45178B65

P2860

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

http://www.wikidata.org/entity/Q24643421

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@ast

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@en

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@nl

type

label

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@ast

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@en

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@nl

prefLabel

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@ast

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@en

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@nl

P1433

Q24643421-7AC60D8D-E321-47CB-8E10-57EA18A03F7D

P1476

Q24643421-3EB6A029-8B01-405F-A259-C590FBBB4477

P2093

Q24643421-0201402E-9AA7-414A-BE1F-ED09F0058CF7

Q24643421-0945DA60-AAF7-470D-9403-71E23A8E054F

Q24643421-17C1BE0D-F35C-42FF-9A45-A2A0F4C0C683

Q24643421-2C30FE81-1882-4100-AF33-EB1DC4089464

Q24643421-361B093F-0000-4FE5-9256-34A204CB530B

Q24643421-36665F1A-8CD4-44F5-8A69-59C633B3DBCD

Q24643421-39A359B4-783A-4A62-AE1C-457618A187D0

Q24643421-3AF60241-4B74-40DD-8E09-4F85191D176E

Q24643421-4BD16EA5-3DC2-41CE-9927-78EBB384F75E

Q24643421-7312077C-4DE7-4EF1-996C-AB4430624C94

P2860

Q24643421-0392B8E1-C75D-4692-A605-A78EE9CC7F55

Q24643421-0E0D302A-68E2-4E8F-B2E3-0BF33F79B771

Q24643421-10179E69-0F2C-45F5-827E-64C009E053F5

Q24643421-10B4DAD0-A2ED-42D6-BD9B-E1EC6B4FF494

Q24643421-129E2E6D-33C5-4563-B866-732201B31209

Q24643421-153943B8-B0D0-4D6E-AFAA-EFA229DDACA9

Q24643421-1828527E-0C51-4F23-A249-F8B1506A5473

Q24643421-18700578-3330-42E5-B17E-19406C7163A5

Q24643421-20FFECAC-0E9B-4FFD-99F1-042EE0CA0D1F

Q24643421-2A42F6C7-435C-40FB-8336-C69B540F97CD

P2888

Q24643421-F8680D32-C6DF-4204-B3EA-E5F455DE3961

P304

Q24643421-813A9A29-BDB3-4988-B424-8B8C63E6110B

P31

Q24643421-590E1EC1-7D31-45AE-87AF-72D8B6D91C27

P3181

Q24643421-5EA037C9-8E46-42F6-80E9-437AAE61B814

P356

Q24643421-0F2382AB-3728-4DE4-93F9-340CC19E0F6F

P407

Q24643421-3AEC21F0-6A64-4C3F-9C31-0720C7D52098

P433

Q24643421-CB1A79FC-01B5-41C5-9330-03EF447C00F7

P478

Q24643421-C709560B-44CF-425E-8987-50756C0B36C9

P50

Q24643421-19C84E2A-4B19-4DF9-9F18-8445F64AEA5C

Q24643421-A86B3419-1501-4E74-B456-23326FC524AB

Q24643421-CA893B61-153B-4453-9EA3-7589D03EFBDA

Q24643421-CF0A6CD1-EB78-4D9A-9C9E-EDA1860D8C41

P577

Q24643421-E82DE588-C343-4372-99E3-A41F6DDD2808

P5875

Q24643421-B851AF23-CE95-4735-968E-838DB02D05F6

P6179

Q24643421-291B69C1-6D32-4792-829D-90E333A21116

P698

Q24643421-82E2BED1-F2E8-4D96-A99A-B73958A06388

P932

Q24643421-1203E7E1-701B-403D-8717-EC0DE2F2D559

P3181

P356

P1433

Nature Genetics

P1476

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

@en

P2093

Barry I Freedman

http://www.w3.org/2001/XMLSchema#string

Cheryl A Winkler

http://www.w3.org/2001/XMLSchema#string

Donald W Bowden

http://www.w3.org/2001/XMLSchema#string

Donna M Michel

http://www.w3.org/2001/XMLSchema#string

Eric Simon

http://www.w3.org/2001/XMLSchema#string

George W Nelson

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kajiyama

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Schelling

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Berns

http://www.w3.org/2001/XMLSchema#string

Louise M McKenzie

http://www.w3.org/2001/XMLSchema#string

P2860

Methods for high-density admixture mapping of disease genes

A high-density admixture map for disease gene discovery in african americans

A second generation human haplotype map of over 3.1 million SNPs

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

A haplotype map of the human genome

The structure of haplotype blocks in the human genome

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis

CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility

Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling

Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice

P2888

P304

1175-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1386054

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG.226

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey B. Kopp

Howard Trachtman

Randall Johnson

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23260330

http://www.w3.org/2001/XMLSchema#string

P6179

1022042808

http://www.w3.org/2001/XMLSchema#string

P698

18794856

http://www.w3.org/2001/XMLSchema#string

P932

2827354

http://www.w3.org/2001/XMLSchema#string